Levexime-500 500 mg Film-Coated Tablet Filipino - Kiingereza - FDA (Food And Drug Administration)

levexime-500 500 mg film-coated tablet

ambica international corporation; distributor: hlm leverege pharmaceutical co. - cefuroxime (as axetil) - film-coated tablet - 500 mg

Levetram 325mg/37.5mg Film Cated Tablet Filipino - Kiingereza - FDA (Food And Drug Administration)

levetram 325mg/37.5mg film cated tablet

gpc geo pharma corporation; distributor: hlm leverege pharmaceutical co. - paracetamol , tramadol hcl - film cated tablet - 325mg/37.5mg

REAPHIRM PLANT SOURCE DHA- prenatal supplement capsule, gelatin coated Marekani - Kiingereza - NLM (National Library of Medicine)

reaphirm plant source dha- prenatal supplement capsule, gelatin coated

everett laboratories, inc. - vitamin a (unii: 81g40h8b0t) (beta carotene - unii:01yae03m7j), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), thiamine mononitrate (unii: 8k0i04919x) (thiamine - unii:x66nso3n35), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacin (unii: 2679mf687a) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), folic acid (unii: 935e97boy8) (fo - beta carotene 1100 [iu] - reaphirm plant source dha is contraindicated in patients with hypersensitivity to any of its components or color additives. folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid. iron therapy is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia, or cirrhosis of the liver. cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (vitamin b12).

SELECT OB- .beta.-carotene, vitamin a acetate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononit Marekani - Kiingereza - NLM (National Library of Medicine)

select ob- .beta.-carotene, vitamin a acetate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononit

everett laboratories, inc. - .beta.-carotene (unii: 01yae03m7j) (.beta.-carotene - unii:01yae03m7j), vitamin a acetate (unii: 3le3d9d6oy) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm297 - .beta.-carotene 600 [iu] - select-ob® is indicated to provide vitamin, mineral supplementation prior to conception, throughout pregnancy, and during the postnatal period for the lactating and non-lactating mother. select-ob® is contraindicated in patients with hypersensitivity to any of its components or color additives. folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid. iron therapy is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia, or cirrhosis of the liver. cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (vitamin b12 ).

SELECT OB- .beta.-carotene, vitamin a acetate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononit Marekani - Kiingereza - NLM (National Library of Medicine)

select ob- .beta.-carotene, vitamin a acetate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononit

everett laboratories, inc. - .beta.-carotene (unii: 01yae03m7j) (.beta.-carotene - unii:01yae03m7j), vitamin a acetate (unii: 3le3d9d6oy) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm297 - .beta.-carotene 600 [iu] - select-ob® chewable caplets are contraindicated in patients with hypersensitivity to any of its components or color additives. folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid. iron therapy is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia, or cirrhosis of the liver. cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (vitamin b12).

VITAFOL PLUS- omega-3 fatty acids, niacin, .alpha.-tocopherol, vitamin d, lauric acid, vitamin a, ascorbic acid, thiamine mononi Marekani - Kiingereza - NLM (National Library of Medicine)

vitafol plus- omega-3 fatty acids, niacin, .alpha.-tocopherol, vitamin d, lauric acid, vitamin a, ascorbic acid, thiamine mononi

everett laboratories, inc. - omega-3 fatty acids (unii: 71m78end5s) (doconexent - unii:zad9okh9jc), niacin (unii: 2679mf687a) (niacinamide - unii:25x51i8rd4), .alpha.-tocopherol (unii: h4n855pnz1) (.alpha.-tocopherol - unii:h4n855pnz1), vitamin d (unii: 9vu1ki44gp) (cholecalciferol - unii:1c6v77qf41), lauric acid (unii: 1160n9nu9u) (lauric acid - unii:1160n9nu9u), vitamin a (unii: 81g40h8b0t) (.beta.-carotene - unii:01yae03m7j), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), thiamine mononitrate (unii: 8k0i0 - omega-3 fatty acids 200 mg - vitafol® -plus is indicated to provide vitamin, mineral and omega-3 fatty acid supplementation prior to conception, throughout pregnancy, and during the postnatal period for the lactating and non-lactating mother, including individuals with known allergies to fish. vitafol® -plus does not contain fish, fish oils, fish proteins or fish byproducts. vitafol® -plus is contraindicated in patients with hypersensitivity to any of its components or color additives. folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid. iron therapy is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc), pyridoxine responsive anemia, or cirrhosis of the liver. cyanocobalamin is contraindicated in patients with sensitivity to co

VITAFOL ONE- prenatal supplement with dha capsule, gelatin coated Marekani - Kiingereza - NLM (National Library of Medicine)

vitafol one- prenatal supplement with dha capsule, gelatin coated

everett laboratories, inc. - vitamin a (unii: 81g40h8b0t) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), folic acid (unii: 935e97boy8) (folic aci - beta carotene 1100 [iu] - vitafol-one is indicated to provide vitamin, mineral, and omega-3 fatty acid supplementation prior to conception, throughout pregnancy, and during the postnatal period for the lactating and non-lactating mother, including individuals with known allergies to fish. vitafol-one does not contain fish, fish oils, fish proteins or fish byproducts. vitafol-one is contraindicated in patients with hypersensitivity to any of its components or color additives. folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid. iron therapy is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia, or cirrhosis of the liver. cyanocobalamin is contraindicated in patients with sensitivity to cobalt or

Wheelchair accessory, <specify> Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

wheelchair accessory, <specify>

dejay medical & scientific pty ltd - 30151 - wheelchair accessory, - componentry for wheelchair seating systems which are used to customise a wheelchair seat for the use.